The first Omicron case has been detected in the U.S.

By BY RONI CARYN RABIN, SHAWN HUBLER AND SHERYL GAY STOLBERG from NYT Health https://ift.tt/3Ib5iDb

Read More

The C.D.C. tells airlines to identify passengers who had recently been in southern Africa.

By BY RONI CARYN RABIN AND NIRAJ CHOKSHI from NYT Health https://ift.tt/3xFDlP2

Read More

More American adults living alone, Census Bureau reports

More American adults are living alone, according to newly released estimates from the U.S. Census Bureau's annual America's Families and Living Arrangement table package.

from Fox News https://ift.tt/31nx5zr

Read More

Fauci says COVID-19 diverted resources from fight against AIDS

Dr. Anthony Fauci, the top U.S. infectious disease expert, said Tuesday the COVID-19 pandemic has diverted scientific and financial resources from the fight against AIDS, seriously impeding global efforts to achieve the U.N. goal of ending AIDS by 2030.

from Fox News https://ift.tt/3rnGFxb

Read More

Travel amidst omicron: WHO says people aged 60 and older should delay travel to certain areas

In guidance released on international travel in relation to the COVID-19 omicron variant, the World Health Organization (WHO) wrote Tuesday that people ages 60 and older should delay travel to "areas with community transmission."

from Fox News https://ift.tt/3roKjqz

Read More

FDA panel endorses first COVID-19 pill

A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.

from Fox News https://ift.tt/3DcPITJ

Read More

FDA approves 'glowing tumor' drug to help surgeons identify ovarian cancer cells

Cytalux (pafolacianince), a drug that binds to ovarian cancer tissue and glows when exposed to fluorescent light, has been approved by the U.S. Food and Drug Administration (FDA) to help surgeons detect ovarian tumors during surgical procedures in patients.

from Fox News https://ift.tt/3d6XxQg

Read More